Erythrocyte membrane and cytoskeletal protein glycation and oxidation in short-term diabetic rabbits

Clinical and Experimental Medicine

Volumn 1, Issue 4, 2001, Pages 187-193

  Resmi, H ^a   Pekcetin C ^a   Guner G ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Carbonyl formation; Erythrocyte; Experimental diabetes; Spectrin; Sulfhydryl oxidation

Indexed keywords

ALLOXAN; AMINOKETONE; CARBONYL DERIVATIVE; CISPLATIN; CYTOSKELETON PROTEIN; FRUCTOSAMINE; HYDRAZINE; MEMBRANE PROTEIN; NITROBLUE TETRAZOLIUM; SPECTRIN; THIOL DERIVATIVE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE MEMBRANE; GEL FILTRATION CHROMATOGRAPHY; GLYCATION; MALE; NONHUMAN; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PURIFICATION; RABBIT; SOLUBILIZATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0035728371     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380100002     Document Type: Article

References (36)

1. Possible significance of advanced glycation end products in serum in end-stage renal disease and late complications of diabetes
2. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
3. Protein degradation as an index of oxidative stress
4. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rats
5. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging
6. Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes
7. Oxidant damage of the lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease
8. Oxidative red blood cell membrane injury in the pathophysiology of severe mouse β-thalassemia
9. Membrane protein lesions in erythrocytes with Heinz Bodies
10. Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties
11. Red cell filterability in diabetes
12. Oxidation of spectrin and deformability defects in diabetic erythrocytes
13. Intimal alterations aortas rabbit in during the first 6 months of alloxan-induced diabetes
14. The preparation and chemical characterisation of hemoglobin-free ghosts of human erythrocytes
15. Purification of two spectrin-binding proteins: Biochemical and electron microscopic evidence for site-specific reassociation between spectrin and bands 2.1 and 4.1
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Determination of carbonyl content in oxidatively modified proteins
18. A novel colorimetric method for determination of glycated protein based on 2-keto-glucose release with hydrazine
19. A modification of the Lowry procedure of simplify protein determination in the membrane and lipoprotein samples
20. Oxidative stress caused by glycation of Cu, Zn-superoxide dismutase and its effects on intracellular components
21. Nonenzymatic glycosylation-induced modifications of intact bovine kidney tubular basement membrane
22. Immunohistochemical detection of imidazolone, a novel advanced glycation end-product, in kidneys and aortas of diabetic patients
23. The role of axonal cytoskeleton in diabetic neuropathy
24. Nonenzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes
25. Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes
26. Determination of glycated proteins in biological samples based on colorimetry of 2-keto-glucose released with hydrazine
27. Metal catalyzed oxidation of proteins. Physiological consequence
28. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents
29. Spectrin based membrane skeleton: A multi-potential adaptor between plasma membrane and cytoplasm
30. Junctional sites of erythrocyte skeletal proteins are specific targets of tert-butylhydroperoxide oxidative damage
31. Comparative toxicity of alloxan, n-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro
32. Similarities in the metabolism of alloxan and dehydroascorbate in human erythrocytes
33. Further proof of oxidative stress in alloxan diabetic rat tissues
34. Diabetogenic action of alloxan in short-term termination of blood supply to the pancreas and spleen
35. Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin
36. Elimination of 14C-glycated albumin from serum of rabbit